TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sun Pharmaceutical Industries Limited ( (IN:SUNPHARMA) ) has provided an update.
Sun Pharmaceutical Industries Limited announced that the U.S. FDA has classified its Halol facility as ‘Official Action Indicated’ (OAI) following an inspection. This classification indicates non-compliance with certain current good manufacturing practices, resulting in an Import Alert that restricts shipments from the facility to the US, except for certain exemptions due to drug shortages. Sun Pharma is committed to resolving these issues and maintaining compliance to continue providing high-quality medicines worldwide.
More about Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is a major player in the pharmaceutical industry, primarily engaged in manufacturing and distributing high-quality medicines globally. The company focuses on maintaining compliance with regulatory standards to ensure the safety and efficacy of its products.
Average Trading Volume: 91,928
Technical Sentiment Signal: Hold
Current Market Cap: 3826.1B INR
For a thorough assessment of SUNPHARMA stock, go to TipRanks’ Stock Analysis page.